Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19

Luo, Huanyuan, Wang, Yuancheng, Liu, Songqiao, Chen, Ruoling, Chen, Tao ORCID: https://orcid.org/0000-0002-5489-6450, Yang, Yi, Wang, Duolao ORCID: https://orcid.org/0000-0003-2788-2464 and Ju, Shenghong (2021) 'Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19'. Internal and emergency medicine, Vol 17, pp. 153-163.

Preview

Text Assoc between CT pulmonary...patients with COVID-19 DWang.pdf - Accepted Version Download (735kB) | Preview

Abstract

This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: ≤ 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single onset, fever, cough, peripheral capillary oxygen saturation, lymphocyte count, platelet count, albumin level, C-reactive protein (CRP) level and fibrinogen level on admission. Patients with score ≥ 41% had a dramatic increased risk of severe or critical illness [odds ratio (OR), 15.58, 95% confidence interval (CI) 3.82-63.53), intensive care unit (ICU)] admission (OR, 6.26, 95% CI 2.15-18.23), respiratory failure (OR, 19.49, 95% CI 4.55-83.40), and a prolonged hospital stay (coefficient, 2.59, 95% CI 0.46-4.72) compared to those with score ≤ 5%. CT pulmonary opacity score on admission, especially when ≥ 41%, was closely related to some clinical characteristics and was an independent predictor of disease severity, ICU admission, respiratory failure and long hospital stay in patients with COVID-19.

Item Type:	Article
Additional Information:	This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
Subjects:	QW Microbiology and Immunology > Viruses > QW 160 Viruses (General). Virology WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 505 Viral respiratory tract infections WF Respiratory System > WF 100 General works WF Respiratory System > Lungs > WF 600 Lungs
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1007/s11739-021-02795-9
Depositing User:	Julie Franco
Date Deposited:	12 Aug 2021 11:01
Last Modified:	30 Jun 2022 01:02
URI:	https://archive.lstmed.ac.uk/id/eprint/18641

Statistics

View details

Actions (login required)

Edit Item